The Global Organization for EPA and DHA Omega-3s (GOED) hosted its first GOED Exchange conference on omega-3s on January 13 to 14 in Salt Lake City.
The Global Organization for EPA and DHA Omega-3s (GOED; Salt Lake City, UT) hosted its first GOED Exchange conference on omega-3s on January 13 to 14 in Salt Lake City.
With more than 150 attendees and 19 educational sessions, the event brought together an unprecedented roster of omega-3 researchers, government officials, regulatory body representatives, and dieticians to hear about the latest omega-3 healthcare innovations, marketing tips and trends, and contamination and sustainability issues facing the industry.
"Our first GOED Exchange served as a powerful reminder of how expansive the omega-3 industry is becoming," said Adam Ismail, GOED executive director. "From omega-3 researchers' findings in the early 1970s to the latest developments in omega-3's role in reducing healthcare costs and its emerging uses in helping children with motor skill disorders, this conference also reminded us that there's still much to discover when it comes to omega-3's health benefits."
Attendees heard from a range of speakers, including: Richard Carmona, MD, MPH, 17th Surgeon General of the United States, who gave the keynote address; Michael Crawford, PhD, one of the earliest innovators in omega-3 studies; and Capt. Joseph Hibbeln, MD, National Institutes of Health. Capt. Hibbeln's message focused on omega-3 advocacy on behalf of enlisted U.S. soldiers and noted that the average soldier's diet includes fewer omega-3 than the average American seven-year-old's – a demographic that is also not meeting recommended intakes.
"Capt. Hibbeln's address on how few omega-3s are included in the average soldier’s diet-and furthermore, how few are in the average American diet-is cause for concern given omega-3s' clinically backed benefits for cardiovascular health and cognitive function. Establishing recommended dietary intakes and enacting measures to ensure omega-3-rich options are available-to soldiers and civilians-remains a top concern for both Capt. Hibbeln and the entire omega-3 industry," Ismail noted.
Ismail also remarked that planning is underway for the next GOED Exchange, with details to be announced later this year. To request materials from this year's conference, including video footage and presentations available for purchase, call 801/746-1413.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.